Eli Lilly CEO on Price Transparency, Loxo Acquisition

Date: 2019-01-08 20:23:27

Jan.08 — Ricks, Chief Executive Officer at Eli Lilly, discusses drug price transparency, the Purchases of Loxo Oncology, and Summand to the company’s via acquisitions. He Speach WITH Bloomberg’s Riggs on “Bloomberg Markets.”

Related posts

Leave a Comment